Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 May 23;92(11):4813–4817. doi: 10.1073/pnas.92.11.4813

CT-2576, an inhibitor of phospholipid signaling, suppresses constitutive and induced expression of human immunodeficiency virus.

D W Leung 1, P K Peterson 1, R Weeks 1, G Gekker 1, C C Chao 1, A H Kaplan 1, N Balantac 1, C Tompkins 1, G E Underiner 1, S Bursten 1, et al.
PMCID: PMC41797  PMID: 7761405

Abstract

Viruses such as human immunodeficiency virus (HIV) require cellular activation for expression. Cellular activation in lymphoid cells is associated with augmented accumulation of certain phosphatidic acid (PA) species derived from the hydrolysis of glycan phosphatidylinositol (GPI). This suggests that activation of a phospholipid pathway may play a role in initiation of viral replication. To test this hypothesis, we examined the effect of tat gene expression on the production of cellular PA species, as the Tat protein is essential for HIV expression and has been implicated in activating the expression of multiple host cellular genes. Expression of tat increased the expression of PA. We then tested whether synthetic inhibitors of PA metabolism would inhibit activation of the HIV long terminal repeat by Tat and tumor necrosis factor alpha (TNF-alpha). CT-2576 suppressed both PA generation induced by Tat and HIV long terminal repeat-directed gene expression in response to Tat or TNF-alpha at a posttranscriptional step. CT-2576 also inhibited constitutive as well as TNF-alpha- and interleukin 6-induced expression of HIV p24 antigen in chronically infected U1 cells and in peripheral blood lymphocytes acutely infected with a clinical isolate of HIV. Pharmacological inhibition of synthesis of selected PA species may therefore provide a therapeutic approach to suppression of HIV replication.

Full text

PDF
4813

Images in this article

4814Fig. 1
on p.4814
4815Fig. 3
on p.4815
4816Fig. 5
on p.4816

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aboulker J. P., Swart A. M. Preliminary analysis of the Concorde trial. Concorde Coordinating Committee. Lancet. 1993 Apr 3;341(8849):889–890. doi: 10.1016/0140-6736(93)93096-j. [DOI] [PubMed] [Google Scholar]
  2. Baeuerle P. A., Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12:141–179. doi: 10.1146/annurev.iy.12.040194.001041. [DOI] [PubMed] [Google Scholar]
  3. Berger J., Hauber J., Hauber R., Geiger R., Cullen B. R. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene. 1988 Jun 15;66(1):1–10. doi: 10.1016/0378-1119(88)90219-3. [DOI] [PubMed] [Google Scholar]
  4. Bonyhadi M. L., Rabin L., Salimi S., Brown D. A., Kosek J., McCune J. M., Kaneshima H. HIV induces thymus depletion in vivo. Nature. 1993 Jun 24;363(6431):728–732. doi: 10.1038/363728a0. [DOI] [PubMed] [Google Scholar]
  5. Brighty D. W., Rosenberg M., Chen I. S., Ivey-Hoyle M. Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor. Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7802–7805. doi: 10.1073/pnas.88.17.7802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Buonaguro L., Barillari G., Chang H. K., Bohan C. A., Kao V., Morgan R., Gallo R. C., Ensoli B. Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines. J Virol. 1992 Dec;66(12):7159–7167. doi: 10.1128/jvi.66.12.7159-7167.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bursten S. L., Harris W. E., Bomsztyk K., Lovett D. Interleukin-1 rapidly stimulates lysophosphatidate acyltransferase and phosphatidate phosphohydrolase activities in human mesangial cells. J Biol Chem. 1991 Nov 5;266(31):20732–20743. [PubMed] [Google Scholar]
  8. Bursten S. L., Harris W. E. Interleukin-1 stimulates phosphatidic acid-mediated phospholipase D activity in human mesangial cells. Am J Physiol. 1994 Apr;266(4 Pt 1):C1093–C1104. doi: 10.1152/ajpcell.1994.266.4.C1093. [DOI] [PubMed] [Google Scholar]
  9. Cachianes G., Ho C., Weber R. F., Williams S. R., Goeddel D. V., Leung D. W. Epstein-Barr virus-derived vectors for transient and stable expression of recombinant proteins. Biotechniques. 1993 Aug;15(2):255–259. [PubMed] [Google Scholar]
  10. Carthew R. W., Chodosh L. A., Sharp P. A. An RNA polymerase II transcription factor binds to an upstream element in the adenovirus major late promoter. Cell. 1985 Dec;43(2 Pt 1):439–448. doi: 10.1016/0092-8674(85)90174-6. [DOI] [PubMed] [Google Scholar]
  11. Dignam J. D., Lebovitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983 Mar 11;11(5):1475–1489. doi: 10.1093/nar/11.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Eardley D. D., Koshland M. E. Glycosylphosphatidylinositol: a candidate system for interleukin-2 signal transduction. Science. 1991 Jan 4;251(4989):78–81. doi: 10.1126/science.1824727. [DOI] [PubMed] [Google Scholar]
  13. Ensoli B., Buonaguro L., Barillari G., Fiorelli V., Gendelman R., Morgan R. A., Wingfield P., Gallo R. C. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation. J Virol. 1993 Jan;67(1):277–287. doi: 10.1128/jvi.67.1.277-287.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ensoli B., Gendelman R., Markham P., Fiorelli V., Colombini S., Raffeld M., Cafaro A., Chang H. K., Brady J. N., Gallo R. C. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature. 1994 Oct 20;371(6499):674–680. doi: 10.1038/371674a0. [DOI] [PubMed] [Google Scholar]
  15. Fauci A. S. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science. 1993 Nov 12;262(5136):1011–1018. doi: 10.1126/science.8235617. [DOI] [PubMed] [Google Scholar]
  16. Frankel A. D., Pabo C. O. Cellular uptake of the tat protein from human immunodeficiency virus. Cell. 1988 Dec 23;55(6):1189–1193. doi: 10.1016/0092-8674(88)90263-2. [DOI] [PubMed] [Google Scholar]
  17. Hofman F. M., Wright A. D., Dohadwala M. M., Wong-Staal F., Walker S. M. Exogenous tat protein activates human endothelial cells. Blood. 1993 Nov 1;82(9):2774–2780. [PubMed] [Google Scholar]
  18. Hsu M. C., Dhingra U., Earley J. V., Holly M., Keith D., Nalin C. M., Richou A. R., Schutt A. D., Tam S. Y., Potash M. J. Inhibition of type 1 human immunodeficiency virus replication by a tat antagonist to which the virus remains sensitive after prolonged exposure in vitro. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6395–6399. doi: 10.1073/pnas.90.14.6395. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hsu M. C., Schutt A. D., Holly M., Slice L. W., Sherman M. I., Richman D. D., Potash M. J., Volsky D. J. Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist. Science. 1991 Dec 20;254(5039):1799–1802. doi: 10.1126/science.1763331. [DOI] [PubMed] [Google Scholar]
  20. Ito T., Jagus R., May W. S. Interleukin 3 stimulates protein synthesis by regulating double-stranded RNA-dependent protein kinase. Proc Natl Acad Sci U S A. 1994 Aug 2;91(16):7455–7459. doi: 10.1073/pnas.91.16.7455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Johnston M. I., Hoth D. F. Present status and future prospects for HIV therapies. Science. 1993 May 28;260(5112):1286–1293. doi: 10.1126/science.7684163. [DOI] [PubMed] [Google Scholar]
  22. Jones K. A., Peterlin B. M. Control of RNA initiation and elongation at the HIV-1 promoter. Annu Rev Biochem. 1994;63:717–743. doi: 10.1146/annurev.bi.63.070194.003441. [DOI] [PubMed] [Google Scholar]
  23. Kaltschmidt C., Kaltschmidt B., Neumann H., Wekerle H., Baeuerle P. A. Constitutive NF-kappa B activity in neurons. Mol Cell Biol. 1994 Jun;14(6):3981–3992. doi: 10.1128/mcb.14.6.3981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kaplan A. H., Michael S. F., Wehbie R. S., Knigge M. F., Paul D. A., Everitt L., Kempf D. J., Norbeck D. W., Erickson J. W., Swanstrom R. Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease. Proc Natl Acad Sci U S A. 1994 Jun 7;91(12):5597–5601. doi: 10.1073/pnas.91.12.5597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kornbluth R. S. Significance of T cell apoptosis for macrophages in HIV infection. J Leukoc Biol. 1994 Sep;56(3):247–256. doi: 10.1002/jlb.56.3.247. [DOI] [PubMed] [Google Scholar]
  26. Lin T. A., Kong X., Haystead T. A., Pause A., Belsham G., Sonenberg N., Lawrence J. C., Jr PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science. 1994 Oct 28;266(5185):653–656. doi: 10.1126/science.7939721. [DOI] [PubMed] [Google Scholar]
  27. Lotz M., Clark-Lewis I., Ganu V. HIV-1 transactivator protein Tat induces proliferation and TGF beta expression in human articular chondrocytes. J Cell Biol. 1994 Feb;124(3):365–371. doi: 10.1083/jcb.124.3.365. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Lu Y. C., Touzjian N., Stenzel M., Dorfman T., Sodroski J. G., Haseltine W. A. Identification of cis-acting repressive sequences within the negative regulatory element of human immunodeficiency virus type 1. J Virol. 1990 Oct;64(10):5226–5229. doi: 10.1128/jvi.64.10.5226-5229.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Merida I., Williamson P., Smith K., Gaulton G. N. The role of diacylglycerol kinase activation and phosphatidate accumulation in interleukin-2-dependent lymphocyte proliferation. DNA Cell Biol. 1993 Jul-Aug;12(6):473–479. doi: 10.1089/dna.1993.12.473. [DOI] [PubMed] [Google Scholar]
  30. Milani D., Zauli G., Neri L. M., Marchisio M., Previati M., Capitani S. Influence of the human immunodeficiency virus type 1 Tat protein on the proliferation and differentiation of PC12 rat pheochromocytoma cells. J Gen Virol. 1993 Dec;74(Pt 12):2587–2594. doi: 10.1099/0022-1317-74-12-2587. [DOI] [PubMed] [Google Scholar]
  31. Nabell L. M., Raja R. H., Sayeski P. P., Paterson A. J., Kudlow J. E. Human immunodeficiency virus 1 Tat stimulates transcription of the transforming growth factor alpha gene in an epidermal growth factor-dependent manner. Cell Growth Differ. 1994 Jan;5(1):87–93. [PubMed] [Google Scholar]
  32. Natarajan V., Iwamoto G. K. Lipopolysaccharide-mediated signal transduction through phospholipase D activation in monocytic cell lines. Biochim Biophys Acta. 1994 Jun 23;1213(1):14–20. doi: 10.1016/0005-2760(94)90216-x. [DOI] [PubMed] [Google Scholar]
  33. Pantaleo G., Graziosi C., Demarest J. F., Cohen O. J., Vaccarezza M., Gantt K., Muro-Cacho C., Fauci A. S. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol Rev. 1994 Aug;140:105–130. doi: 10.1111/j.1600-065x.1994.tb00867.x. [DOI] [PubMed] [Google Scholar]
  34. Pelaez F., de Haro C. Translational inhibition by eIF-2-phospholipid complex in mammalian cell-free systems. FEBS Lett. 1989 Jul 3;250(2):523–528. doi: 10.1016/0014-5793(89)80789-6. [DOI] [PubMed] [Google Scholar]
  35. Peterson P. K., Gekker G., Chao C. C., Hu S. X., Edelman C., Balfour H. H., Jr, Verhoef J. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-alpha-mediated mechanism. J Clin Invest. 1992 Feb;89(2):574–580. doi: 10.1172/JCI115623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Poli G., Kinter A. L., Fauci A. S. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc Natl Acad Sci U S A. 1994 Jan 4;91(1):108–112. doi: 10.1073/pnas.91.1.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Proud C. G. Translation. Turned on by insulin. Nature. 1994 Oct 27;371(6500):747–748. doi: 10.1038/371747a0. [DOI] [PubMed] [Google Scholar]
  38. Rice G. C., Brown P. A., Nelson R. J., Bianco J. A., Singer J. W., Bursten S. Protection from endotoxic shock in mice by pharmacologic inhibition of phosphatidic acid. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3857–3861. doi: 10.1073/pnas.91.9.3857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Rosenberg Z. F., Fauci A. S. Induction of expression of HIV in latently or chronically infected cells. AIDS Res Hum Retroviruses. 1989 Feb;5(1):1–4. doi: 10.1089/aid.1989.5.1. [DOI] [PubMed] [Google Scholar]
  40. Schwarz A., Offermann G., Keller F., Bennhold I., L'age-Stehr J., Krause P. H., Mihatsch M. J. The effect of cyclosporine on the progression of human immunodeficiency virus type 1 infection transmitted by transplantation--data on four cases and review of the literature. Transplantation. 1993 Jan;55(1):95–103. doi: 10.1097/00007890-199301000-00019. [DOI] [PubMed] [Google Scholar]
  41. Short N. A fight to the death. Nat Med. 1995 Feb;1(2):122–124. doi: 10.1038/nm0295-122. [DOI] [PubMed] [Google Scholar]
  42. Sodroski J., Rosen C., Wong-Staal F., Salahuddin S. Z., Popovic M., Arya S., Gallo R. C., Haseltine W. A. Trans-acting transcriptional regulation of human T-cell leukemia virus type III long terminal repeat. Science. 1985 Jan 11;227(4683):171–173. doi: 10.1126/science.2981427. [DOI] [PubMed] [Google Scholar]
  43. Tate S. S., Urade R., Micanovic R., Gerber L., Udenfriend S. Secreted alkaline phosphatase: an internal standard for expression of injected mRNAs in the Xenopus oocyte. FASEB J. 1990 Feb 1;4(2):227–231. doi: 10.1096/fasebj.4.2.2298343. [DOI] [PubMed] [Google Scholar]
  44. Zeichner S. L. The molecular biology of HIV. Insights into pathogenesis and targets for therapy. Clin Perinatol. 1994 Mar;21(1):39–73. [PubMed] [Google Scholar]
  45. de Haro C., de Herreros A. G., Ochoa S. Formation of a translational inhibitor by interaction of phospholipid with the eukaryotic initiation factor 2. Proc Natl Acad Sci U S A. 1986 Sep;83(18):6711–6715. doi: 10.1073/pnas.83.18.6711. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES